Brady Johnson, Vice President, Finance at Cidara Therapeutics, Inc. (CDTX), sold 654 shares at $0.81 ($530) on 2022-03-21, disclosed to the SEC on 2022-03-23.
Open-market sale of $530 CDTX by Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |